T1	Intervention 643 808	either enoxaparin (n = 10) or UFH (n = 11) anticoagulation and followed prospectively for 12 weeks before crossing over to the alternate therapy for further 12 weeks
T2	Intervention 810 921	The OPG, RANKL, and vWF levels were measured at T0, T10, and T180 of HD session after each period of evaluation
